Australia markets closed

OncoSil Medical Limited (OSL.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0050+0.0010 (+25.00%)
At close: 04:10PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 11.28M
Enterprise value 6.49M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)33.34
Price/book (mrq)2.76
Enterprise value/revenue 27.13
Enterprise value/EBITDA -0.53

Trading information

Stock price history

Beta (5Y monthly) 0.35
52-week change 3-54.55%
S&P500 52-week change 325.01%
52-week high 30.0150
52-week low 30.0040
50-day moving average 30.0069
200-day moving average 30.0088

Share statistics

Avg vol (3-month) 33.39M
Avg vol (10-day) 35.47M
Shares outstanding 52.26B
Implied shares outstanding 62.26B
Float 81.54B
% held by insiders 123.93%
% held by institutions 12.18%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-946.57%

Management effectiveness

Return on assets (ttm)-103.64%
Return on equity (ttm)-237.87%

Income statement

Revenue (ttm)1.3M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-20.90%
Gross profit (ttm)N/A
EBITDA -11.64M
Net income avi to common (ttm)-11.71M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.89M
Total cash per share (mrq)0
Total debt (mrq)107.12k
Total debt/equity (mrq)2.62%
Current ratio (mrq)2.74
Book value per share (mrq)0.00

Cash flow statement

Operating cash flow (ttm)-10.22M
Levered free cash flow (ttm)-5.93M